Hypercross-labelled dermal filler based on non-animal HA. Enhanced density and elasticity technology, free of residues including lidocaine.
exquiller’s unique manufacturing process benefits from single-phase and two-phase HA qualities driven through enhanced cross-linking technology and an optimised purification process, helping to ensure safety, long-lasting effect and high satisfaction rate.
About exquiller
Hypercross-labelled dermal filler based on non-animal HA. Enhanced density and elasticity technology, free of residues including lidocaine.
exquiller’s unique manufacturing process benefits from single-phase and two-phase HA qualities driven through enhanced cross-linking technology and an optimised purification process, helping to ensure safety, long-lasting effect and high satisfaction rate.
About exquiller
Hypercross-labelled dermal filler based on non-animal HA. Enhanced density and elasticity technology, free of residues including lidocaine.
exquiller’s unique manufacturing process benefits from single-phase and two-phase HA qualities driven through enhanced cross-linking technology and an optimised purification process, helping to ensure safety, long-lasting effect and high satisfaction rate.
Hybrid Technology
guarantees 3 values for exquiller
Improved security
Exquiller passed 1st, 2nd, 3rd
Korean clinical trials
Institutional Review Board, and its safety was officially approved by the Korean government and the EU (EC) (*Not tested on animals).
Lasting effect
Exquiller ambivalence and high crosslinking rate guarantee a long-lasting effect.
High satisfaction
Approved clinical data and most patient reports show (prove) long-lasting moulding results of exquiller.
